Detalhe da pesquisa
1.
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report.
Value Health
; 21(10): 1133-1149, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30314613
2.
The temporal impact of aging on the burden of herpes zoster.
BMC Geriatr
; 17(1): 30, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114907
3.
Budget constraint and vaccine dosing: a mathematical modelling exercise.
Cost Eff Resour Alloc
; 12(1): 3, 2014 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450591
4.
The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country.
Vaccines (Basel)
; 11(5)2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243021
5.
Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990.
Vaccines (Basel)
; 11(11)2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38005978
6.
Discounting health gain: a different view.
J Mark Access Health Policy
; 11(1): 2275350, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37937314
7.
Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.
Vaccines (Basel)
; 11(2)2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851254
8.
Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe.
Viruses
; 14(2)2022 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216018
9.
Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium.
Vaccine
; 40(13): 1948-1957, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190208
10.
Infections and hospital bed-days among aging adults: A five-year retrospective study in a Belgian general hospital.
Front Med Technol
; 4: 912469, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36340588
11.
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
Hum Vaccin Immunother
; 18(7): 2135916, 2022 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36507685
12.
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.
BMC Med
; 9: 84, 2011 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21740545
13.
Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs.
Pharmacoeconomics
; 39(2): 257-269, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236330
14.
Informing decision makers seeking to improve vaccination programs: case-study Serbia.
J Mark Access Health Policy
; 9(1): 1938894, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34367530
15.
Constrained Optimization for Pneumococcal Vaccination in Brazil.
Value Health Reg Issues
; 26: 40-49, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33848895
16.
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned.
Expert Rev Vaccines
; 19(8): 755-769, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729747
17.
Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS).
Infect Dis Ther
; 9(4): 967-980, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025558
18.
Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework.
Expert Rev Pharmacoecon Outcomes Res
; 20(6): 603-612, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755345
19.
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future.
J Mark Access Health Policy
; 8(1): 1719588, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128075
20.
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project.
Vaccine
; 38(37): 5896-5904, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713682